A San Francisco death linked to MGM-15, found in a product sold as “cat’s claw,” shows how a fast-changing, mislabeled opioid market sits entirely outside prescription monitoring.
Read More
The Justice Department’s October 22 announcement pairs what DOJ calls its largest sober-home fraud case with cases flagged by billing analytics, a combination that speaks directly to how treatment integrity is policed.
Read More
As the veterinary sedative medetomidine displaces xylazine in Philadelphia and parts of the Northeast and Midwest, a single case report and a transport study add detail to a withdrawal syndrome that can require intensive care.
Read More
University of Iowa researchers looked at 13 years of state PDMP policy and found that mandatory...
Read More
A Monash University survey of community pharmacists in Victoria, Australia, found that the share...
Read More
A survey of 601 adults treated for opioid use disorder by telemedicine in five states found that...
Read More
People with opioid use disorder who received medication while held in seven Massachusetts county...
Read More
A baseline review at Baptist Health in Florida found inconsistent opioid tolerance documentation...
Read More
A small survey of healthcare consumers in New South Wales, Australia, found low awareness of...
Read More
A transparent model that predicts new long-term opioid use performed about as well as...
Read More
New DEA Telemedicine Rule and Mandates 1. Introduction: The Post-Pandemic Pivot The ticking clock...
Read More
A Strategic Funding Opportunity An investigation reveals a critical oversight in how states are...
Read More